John K. Sullivan
13Patents
7h-index
22Co-inventors
62Inventor score
Filing activity: Sep 25, 1998 → Jan 27, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8907071B2 | Toxin peptide therapeutic agents | Chemistry; Metallurgy | 57 | Active |
| US7803769B2 | OSK1 peptide analogs and pharmaceutical compositions | Chemistry; Metallurgy | 37 | Active |
| US7833979B2 | Toxin peptide therapeutic agents | Chemistry; Metallurgy | 36 | Active |
| US7414122B2 | Nucleic acids encoding B7-Like molecules and uses thereof | Chemistry; Metallurgy | 32 | Expired |
| US6344541B1 | DKR polypeptides | Chemistry; Metallurgy | 23 | Expired |
| US7834164B2 | DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression | Chemistry; Metallurgy | 9 | Active |
| US7820623B2 | Conjugated toxin peptide therapeutic agents | Chemistry; Metallurgy | 7 | Active |
| US8043829B2 | DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression | Chemistry; Metallurgy | 4 | Active |
| US7825093B2 | Methods of using OSK1 peptide analogs | Chemistry; Metallurgy | 3 | Active |
| US7910102B2 | Methods of using conjugated toxin peptide therapeutic agents | Chemistry; Metallurgy | 3 | Active |
| US7723478B2 | DKR polypeptides | Chemistry; Metallurgy | 2 | Active |
| US8367063B2 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8455629B2 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.